Table 1 Patient baseline characteristics
From: IMRT and carbon ion boost for malignant salivary gland tumors: interim analysis of the COSMIC trial
R2: visible residual tumor | R1: R1/ Pn + resected tumors | |
|---|---|---|
Patient number | 16 | 13 |
Prior surgery | 7 | 13 |
Recurrent tumors | 3 | 2 |
Median age (years) | 56 | 55 |
Range (years) | 27-74 | 25-72 |
Stages | ||
T1 | 0 | 0 |
T2 | 2 | 1 |
T3 | 2 | 4 |
T4 | 11 | 6 |
Tx | 1 | 2 |
N0 | 13 | 9 |
N1 | 2 | 0 |
N2b | 1 | 2 |
M1 | 3 | 0 |
Histology | ||
Adenoid cystic carcinoma | 16 | 8 |
Mucoepidermoid carcinoma | 0 | 3 |
Adenocarcinoma | 0 | 1 |
Squamous cell carcinoma | 0 | 1 |
Site | ||
Base of skull | 0 | 1 |
Paranasal sinus | 7 | 3 |
Palate | 0 | 1 |
Nasopharynx | 3 | 0 |
External auditory canal | 1 | 0 |
Parotid gland | 3 | 2 |
Submandibular gland | 1 | 4 |
Lacrimal gland | 1 | 1 |
Lacrimal duct | 0 | 1 |